alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › identification

identification

9 studies tagged identification, dated 2002-01-01 to 2025-12-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brain 2025-12-22
  2. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China 2024-12-23
  3. Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease 2022-03-12

Studies

9 studies carry this tag.

Date range

2002 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Frontiers in aging neuroscience 2
  • BMC biology 1
  • Cell reports. Medicine 1
  • Frontiers in cellular neuroscience 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brain

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Cell reports. Medicine 2025-12-22 Biomarkers

    Alzheimer's disease (AD) is traditionally considered irreversible.

  2. Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-12-23 Biomarkers

    The common and distinct risk factors across cognitive decline stages emphasize the need for tailored interventions.

  3. Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-03-12 Biomarkers

    We conclude that the Aβ 37/42 ratio sensitively detects presenilin/γ-secretase dysfunction and better distinguishes CN from AD than Aβ42/40 in CSF.

  4. Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Journal of Alzheimer's disease : JAD 2022-01-01 Biomarkers

    The recent development of ultrasensitive technology allows the determination of blood-based biomarkers with high sensitivity, thus facilitating the early detection of AD through the analysis of easily obtained biological samples.

  5. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Frontiers in aging neuroscience 2021-10-27 Biomarkers

    After adjusting for age, sex, and the apolipoprotein E ( APOE ) alleles, compared to the CN group, the plasma t-tau, and NfL were significantly increased in the AD group ( p < 0.01, Bonferroni correction).

  6. Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Frontiers in aging neuroscience 2021-05-28 Biomarkers

    The rate of cognitive decline among patients with amnestic mild cognitive impairment (aMCI) varies, and it is thus crucial to accurately predict the probability of cognitive deterioration in patients with MCI.

  7. Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. BMC biology 2016-03-31 Biomarkers

    Our findings identify Syt1 as a novel Ca(2+)-sensitive PS1 modulator that could regulate synaptic Aβ, opening avenues for novel and selective synapse targeting therapeutic strategies.

  8. Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in cellular neuroscience 2015-02-19 Biomarkers

    Alzheimer's disease (AD) is a neurodegenerative disorder characterized clinically by the progressive decline of memory and cognition.

  9. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2002-01-01 Biomarkers

    Chronic neuroinflammatory processes including glial activation may play a role in the pathogenesis of Alzheimer's disease (AD).

All topic tags with their study counts